Spark Investment Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Spark Investment Management’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-18,500	Closed	-$283K	–	930
2015 Q3	$283K	Sell	18,500 -61,000	-77%	-$1.32M	0.04%	474
2015 Q2	$1.93M	Sell	79,500 -17,000	-18%	-$407K	0.27%	117
2015 Q1	$2.24M	Sell	96,500 -16,300	-14%	-$431K	0.31%	89
2014 Q4	$2.83M	Buy	112,800 +35,700	+46%	+$1.05M	0.48%	47
2014 Q3	$2.4M	Buy	77,100 +39,000	+102%	+$1.06M	0.36%	76
2014 Q2	$983K	Buy	+38,100	New	+$846K	0.15%	223
2013 Q4	–	Sell	-37,800	Closed	-$771K	–	757
2013 Q3	$771K	Buy	37,800 +5,000	+15%	+$111K	0.18%	178
2013 Q2	$688K	Buy	+32,800	New	+$586K	0.18%	152

Other funds holding SGNT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Spark Investment Management's SGNT Position: Q4 2015 in Review

Spark Investment Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q4 2015, closing a stake of 18,500 shares — an estimated $283K sold.

Spark Investment Management first reported a position in SGNT in Q2 2013 and held it in 8 quarters. The position peaked at $2.83M in Q4 2014. 134 funds tracked by Wall St. Rank hold SGNT as of Q4 2015.

Spark Investment Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
Spark Investment Management sold 18,500 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015, an estimated $283K.
Spark Investment Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
Spark Investment Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $2.83M in Q4 2014.
134 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Spark Investment Management's 13F filing for Q4 2015, filed 12 Feb 2016.